Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma
Rapalogues for Autism Phenotype in TSC: A Feasibility Study
|4||Active, not recruiting||
Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)
† Study has passed its completion date and status has not been verified in more than two years.